Consent to Publish Sample Clauses

Consent to Publish. In consideration of the publication by the Society of the above named manuscript, the undersigned Author(s) transfer(s) exclusively to the Society all rights defined by the Copyright Law of the United States in and to the above named manuscript in its entirety, including all subsidiary rights throughout the world in any form and in any language (including all media, both now known or later developed). The rights transferred herein shall remain the property of the Society for the full duration of these rights under the Copyright Law of the United States. The Society may assign its rights under this agreement. If it should become necessary, the Author(s) agree(s) to assist the Society in registering the Copyright in the name of the Society. The Society, in turn, grants to the Author(s) the right to republication in any book in which he or she is the author or editor and distribution in any class in which he or she is the teacher, and posting on the author(s)'s personal or their institutions website, subject only to the Author(s) giving proper credit in any book or on the copies distributed in class, or on the website, to the original publication in Econometrica.
AutoNDA by SimpleDocs
Consent to Publish. In signing this form, you grant the Press the full copyright in the Work and authorize us to register the Work in the United States and elsewhere in the name of the Press. By this assignment of copyright you grant and transfer to the Press the exclusive right to publish print, reproduce, display publicly, distribute, transmit and sell the Work in all forms, languages, and media throughout the world during the full term of the copyright and to allow others to do any of the foregoing. Assignment of copyright entails the transfer of rights including, but not limited to: (a) publishing and/or licensing publication of the Work in a hardcover and/or paperbound edition; (b) publishing and/or licensing publication or distributing the Work or portions thereof in digitized or audio or audio-visual media or in other media or forms not yet invented; (c) publishing and/or licensing publication of translations of the Work; (d) granting permission for use of material in the Work (as is or in digested, abridged, condensed, or adapted form), except insofar as already copyrighted by others; (e) licensing publication and production of a book club edition of the Work by book clubs; (f) publishing and/or licensing publication of a large-print edition; (g) serializing excerpts of the Work at any time before or after publication; and (h) licensing motion picture, dramatization, radio, and television rights. All rights assigned to the Press in this Article 1 apply to such subsidiary rights in the Work, in all forms, languages and media throughout the World. The title of the Work and any series titles used on or with it shall also belong to the Press. The Press may use the name, likeness, and professional credits of the Author on and in connection with any edition or derivative version of the Work. The Press shall have the right to license any or all of these rights, directly or through an entity such as the Copyright Clearance Center, and we shall have the right to grant to the Library of Congress a nonexclusive license to reproduce the Work in Braille (or similar tactile symbols) or in audio form for distribution to persons with visual or physical disabilities. The Press, in turn, grants you the right to republish your Contribution in any book of which you are the author or editor, subject only to your giving proper credit in that book to the original publication of the Contribution by the Press.
Consent to Publish. I irrevocably grant and agree that UEA shall have the right to use, air, publish or reproduce photographs, video and/or pictures of my name, image and
Consent to Publish. Notwithstanding the foregoing, University agrees that it shall not publish the results of research and testing conducted in connection with this Agreement, without the prior written consent of Sponsor, until the expiration of six (6) months following the first to occur of either the termination of this Agreement or submission to Sponsor of at least ten (10) complete and accurate CRFs, pursuant to Sections 1 and 4, hereof.
Consent to Publish. Notwithstanding the survival of Article 12, FRTX hereby grants Carna written consent to publish and present any and all Licensor Know-How at any time now or in the future. No other part of Article 12 is modified by this Agreement.
Consent to Publish. I/we certify that I/We have obtained written informed consent from the patient(s)/subject(s), for publication of this Manuscript, accompanying images and other data. If necessary, a copy of the signed consent form is available for review by the Journal. Consent was obtained from: Patient Father Mother Spouse Children Legal Guardian Relatives Other I/we certify that I/We have NOT obtained written informed consent from the patient(s)/subject(s), for publication of this Manuscript, accompanying images and other data Not Applicable to this Manuscript If written, informed consent was not obtained, please state the reason for not obtaining the consent.
Consent to Publish. In consideration of the publication by the JEFE of the above named manuscript, the undersigned as Author(s) transfers exclusively to the JEFE all rights defined by the Copyright Law of the United States in and to the above named manuscript in its entirety, including all subsidiary rights. The rights transferred herein shall remain the property of the JEFE for the full duration of these rights under the Copyright Law of the United States. If it should become necessary, the Author(s) agree(s) to assist the JEFE in registering the Copyright in the name of the JEFE. The JEFE, in turn, grants to the Author(s) the right to republication in any work in which he or she is the author or editor. The JEFE further grants to the Author(s) the right to distribute the above-noted work in any classroom in which he or she is teacher, subject only to the Author(s) giving proper credit in any such derivative work and on any copies distributed for classroom use. Proper notice may be given as follows: [Copyright, 1998, Journal of Economics and Finance Education; reproduced with permission of the Journal of Economics and Finance Education.]
AutoNDA by SimpleDocs

Related to Consent to Publish

  • Right to Publish Throughout the duration of this Master Agreement, Contractor must secure from the Lead State prior approval for the release of information that pertains to the potential work or activities covered by the Master Agreement. This limitation does not preclude publication about the award of the Master Agreement or marketing activities consistent with any proposed and accepted marketing plan. The Contractor shall not make any representations of NASPO ValuePoint’s opinion or position as to the quality or effectiveness of the services that are the subject of this Master Agreement without prior written consent. Failure to adhere to this requirement may result in termination of the Master Agreement for cause.

  • Consent to Disclosure Each Company Shareholder consents to and authorizes the Company or SPAC, as applicable, to publish and disclose in all documents and schedules filed with the SEC or any other Governmental Entity or applicable securities exchange, and any press release or other disclosure document that the Company or SPAC, as applicable, reasonably determines to be necessary or advisable in connection with the Mergers or any other transactions contemplated by the Merger Agreement or this Agreement, such Company Shareholder’s identity and ownership of such Company Shareholder’s Subject Shares, the existence of this Agreement and the nature of such Company Shareholder’s commitments and obligations under this Agreement, and such Company Shareholder acknowledges that the Company or SPAC may, in their sole discretion, file this Agreement or a form hereof with the SEC or any other Governmental Entity or securities exchange. Such Company Shareholder agrees to promptly give the Company or SPAC, as applicable, any information that is in its possession that the Company or SPAC, as applicable, may reasonably request for the preparation of any such disclosure documents, and such Company Shareholder agrees to promptly notify the Company and SPAC of any required corrections with respect to any written information supplied by it specifically for use in any such disclosure document, if and to the extent that such Company Shareholder shall become aware that any such information shall have become false or misleading in any material respect.

  • Consent to Use of Data You grant NCR Voyix a perpetual, non-exclusive, irrevocable, sub-licensable, transferrable license to use the data transmitted through the Platform: (a) to provide the NCR Voyix Product and the Platform as well as related products, software, materials and services under this Agreement or another agreement between you and NCR Voyix; (b) for product and service enhancements, as well as research and development purposes; and (c) after it has been aggregated, for analytics, commercial and benchmarking purposes.

  • Consent to Service Each party irrevocably consents to the service of process by registered or certified mail, postage prepaid, to it at its address given pursuant to Article XVIII hereof.

  • CONSENT TO AGREEMENT You acknowledge receipt of a copy of this Agreement. By signing the application; or by using Your Account or any Account access device; or by authorizing another to use Your Account, You agree to and accept its terms.

  • Approval for Publishing The Author shall proofread the page proofs for the Contribution provided by or on behalf of the Publisher, including checking the illustrations as well as any media, social or functional enhancements and give approval for publishing, if and when requested by the Publisher. The Author’s approval for publishing is deemed to have been given if the Author does not respond within a reasonable period of time (as determined by the Publisher) after receiving the proofs nor contacts the Publisher within three days after receipt of the last of three reminders sent by the Publisher via email. The Publisher shall not be required to send a second set of corrected proofs unless specifically requested by the Author in writing but in any event no further amendments may be made or requested by the Author. In the event of co-authors having entered into this Agreement the Publisher shall send the page proofs to the Corresponding Author only and all persons entering into this Agreement as Author agree that the Corresponding Author shall correct and approve the page proofs on their behalf. If the Author makes changes other than correcting typographical errors, the Author shall bear all the Publisher's costs of such alterations to proofs including without limitation to alterations to pictorial illustrations. The Publisher shall have the right to charge and invoice these costs plus value added or similar taxes (if applicable) through its affiliated company Springer Nature Customer Service Center GmbH or Springer Nature Customer Service Center LLC, respectively, to the Author, payable within 14 days of receipt of the invoice.

  • Non-Publication The parties mutually agree not to disclose publicly the terms of this Agreement except to the extent that disclosure is mandated by applicable law or regulation or to their respective advisors (e.g., attorneys, accountants).

  • Consent to Forum EACH OBLIGOR HEREBY CONSENTS TO THE NON-EXCLUSIVE JURISDICTION OF ANY FEDERAL OR STATE COURT SITTING IN OR WITH JURISDICTION OVER NEW YORK, IN ANY PROCEEDING OR DISPUTE RELATING IN ANY WAY TO ANY LOAN DOCUMENTS, AND AGREES THAT ANY SUCH PROCEEDING SHALL BE BROUGHT BY IT SOLELY IN ANY SUCH COURT. EACH OBLIGOR IRREVOCABLY WAIVES ALL CLAIMS, OBJECTIONS AND DEFENSES THAT IT MAY HAVE REGARDING SUCH COURT’S PERSONAL OR SUBJECT MATTER JURISDICTION, VENUE OR INCONVENIENT FORUM. EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN SECTION 14.3. 1. Nothing herein shall limit the right of Agent or any Lender to bring proceedings against any Obligor in any other court, nor limit the right of any party to serve process in any other manner permitted by Applicable Law. Nothing in this Agreement shall be deemed to preclude enforcement by Agent of any judgment or order obtained in any forum or jurisdiction.

  • Consent to Suit In the case of any dispute under or in connection with this Agreement, the Indemnitee may only bring suit against the Corporation in the Court of Chancery of the State of Delaware. The Indemnitee hereby consents to the exclusive jurisdiction and venue of the courts of the State of Delaware, and the Indemnitee hereby waives any claim the Indemnitee may have at any time as to forum non conveniens with respect to such venue. The Corporation shall have the right to institute any legal action arising out of or relating to this Agreement in any court of competent jurisdiction. Any judgment entered against either of the parties in any proceeding hereunder may be entered and enforced by any court of competent jurisdiction.

  • Scientific Publications During the Research Program Term, neither Party shall first publish or first present in a public forum the scientific or technical results of any activity performed pursuant to this Agreement without the opportunity for prior review and comment by the other Party. Each Party agrees to provide the other Party with the opportunity to review any proposed abstract, manuscript or scientific presentation (including any verbal presentation) that relates to its activities performed pursuant to this Agreement during the Research Program Term, at least [**] days prior to its intended submission for publication and agrees, upon request, not to submit any such abstract or manuscript for publication until the other Party is given a reasonable period of time up to [**] to secure patent protection for any material in such publication that it believes to be patentable. Both Parties understand that a reasonable commercial strategy may require delay of publication of information or filing of patent applications first with respect to activities performed or results obtained pursuant to this Agreement during the Research Program Term, or not to publish at all if necessary to preserve trade secrets. The Parties agree to review and decide whether to delay publication of such information to permit filing of patent applications. Neither Party shall have the right to publish or present any Confidential Information of the other Party, except as provided in Section 9.2. After the Research Program Term, each Party and its Affiliates may publish or present results, data or scientific findings of any of their activities without the prior review of the other Party, provided that such publication or presentation does not disclose any of the other Party’s Confidential Information. Nothing contained in this Section 9.3 shall prohibit the inclusion of information necessary for a patent application; provided that the non-filing Party is given a reasonable opportunity to review the information to be included prior to submission of such patent application in accordance with Section 8.2. Nothing contained in this Section 9.3 shall prohibit either Party from disclosing the results, data or scientific findings of any activity performed by the other Party or its Affiliates pursuant to this Agreement without prior review and prior written consent of the other Party, where required, as reasonably determined by the disclosing Party’s legal counsel, by applicable law; provided that if a Party is required by law to make any such disclosure, to the extent it may legally do so, it will give reasonable advance notice to the other Party of such disclosure and will use its reasonable efforts to secure confidential treatment of such information prior to its disclosure (whether through protective orders or otherwise).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!